Study quality of care for adults living with HIV
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This trial looks at how care is being provided to adults with HIV who may be on treatment or not, and regardless of immune strength. It may help improve future care plans by identifying what works best in real-world settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be age 18 or older
- You must have HIV-1 infection
- You must be able to give written informed consent
- Your CD4 count (immune cell level) does not matter for joining
- Whether you take HIV medicines does not matter for joining
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether getting HIV care through a community program is as helpful as going to a clinic for people who just found out they have HIV. It looks at how well they stay in care and take their medicine.
This study aims to improve the quality of life and care for people living with HIV. Researchers will talk with participants to understand their experiences and needs.
This study gathers and reviews existing records from people receiving care for HIV in South Africa. It aims to better understand how HIV treatment is working in real-world settings and for different types of risk groups.
This study tests how well researchers can track HIV-related health and immune changes over time by collecting blood and other samples. It may help you and your care team by creating detailed monitoring, even if your HIV diagnosis is new or still being evaluated.
This trial uses health records to learn how people in Zambia access HIV care and treatments. It may help improve future HIV support and treatment planning.
This trial helps hospitals find undiagnosed HIV by improving testing and care. It supports healthcare teams to identify HIV in people with certain conditions and ensures those diagnosed get connected to treatment.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.